No Data
No Data
Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025
Press Release: Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
Wall Street Analysts Believe Cybin Inc. (CYBN) Could Rally 952.23%: Here's Is How to Trade
Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025